Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

CardioPET as PET Imaging Agent to Assess Myocardial Perfusion and Fatty Acid Uptake in Known or Suspected CAD Subjects

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Fluoropharma, Inc.
ClinicalTrials.gov Identifier:
NCT01826773
First received: April 4, 2013
Last updated: November 25, 2015
Last verified: November 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2015
  Primary Completion Date: November 2015 (Final data collection date for primary outcome measure)